Liminatus Pharma, Inc. (LIMN)
0.8462
-0.02
(-2.06%)
USD |
NASDAQ |
Dec 09, 14:55
Liminatus Pharma Market Cap: 22.90M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CDT Equity, Inc. | 2.900M |
| LENZ Therapeutics, Inc. | 820.42M |
| Oruka Therapeutics, Inc. | 1.496B |
| Maze Therapeutics, Inc. | 1.971B |
| MapLight Therapeutics, Inc. | 799.51M |
Market Cap Related Metrics
| PEG Ratio | -0.1329 |
| Price | 0.8462 |
| Earnings Yield | -21.90% |
| PEGY Ratio | -0.1329 |